Clinical Trial Update: Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating continuous oral contraceptive treatment for Premenstrual Dysphoric Disorder has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Dysphoric Disorder

Drugs mentioned

• Oral contraceptive

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Premenstrual Dysphoric Disorder | Phase 4 | Status: COMPLETED | Results posted: 2016-08-24